{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:38:40Z","timestamp":1791405520967,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113840","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T07:49:25Z","timestamp":1734335365000},"page":"113840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Neutrophil extracellular traps as a potential marker of systemic lupus erythematosus activity"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5343-481X","authenticated-orcid":false,"given":"Yanli","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengli","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianci","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113840_b0005","article-title":"COVID GEAS: COVID-19 national survey in patients with systemic autoimmune diseases","volume":"8","author":"Gracia","year":"2021","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113840_b0010","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s10238-022-00942-w","article-title":"Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity","volume":"23","author":"Zeng","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2024.113840_b0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s40064-016-2462-4","article-title":"CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients","volume":"5","author":"Zeng","year":"2016","journal-title":"Springerplus"},{"issue":"1","key":"10.1016\/j.intimp.2024.113840_b0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41420-022-01166-3","article-title":"Neutrophil extracellular traps-triggered impaired autophagic flux via METTL3 underlies sepsis-associated acute lung injury","volume":"8","author":"Qu","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.intimp.2024.113840_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109843","article-title":"Neutrophil extracellular trap: A key player in the pathogenesis of autoimmune diseases","volume":"116","author":"Sadeghi","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0030","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113840_b0035","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A","article-title":"A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0040","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","article-title":"P-selectin promotes neutrophil extracellular trap formation in mice","volume":"126","author":"Etulain","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2024.113840_b0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12967-020-02604-5","article-title":"Conformational changes in myeloperoxidase induced by ubiquitin and NETs containing free ISG15 from systemic lupus erythematosus patients promote a pro-inflammatory cytokine response in CD4(+) T cells","volume":"18","author":"Carrillo-V\u00e1zquez","year":"2020","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.intimp.2024.113840_b0050","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0055","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.020502","article-title":"Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine","volume":"31","author":"Te\u0161ija Kuna","year":"2021","journal-title":"Biochem Med (zagreb)"},{"key":"10.1016\/j.intimp.2024.113840_b0060","doi-asserted-by":"crossref","unstructured":"M. Aringer, K. Costenbader, D. Daikh, R. Brinks, M. Mosca, R. Ramsey-Goldman, J.S. Smolen, D. Wofsy, D.T. Boumpas, D.L. Kamen, D. Jayne, R. Cervera, N. Costedoat-Chalumeau, B. Diamond, D.D. Gladman, B. Hahn, F. Hiepe, S. Jacobsen, D. Khanna, K. Lerstr\u00f8m, E. Massarotti, J. McCune, G. Ruiz-Irastorza, J. Sanchez-Guerrero, M. Schneider, M. Urowitz, G. Bertsias, B.F. Hoyer, N. Leuchten, C. Tani, S.K. Tedeschi, Z. Touma, G. Schmajuk, B. Anic, F. Assan, T.M. Chan, A.E. Clarke, M.K. Crow, L. Czirj\u00e1k, A. Doria, W. Graninger, B. Halda-Kiss, S. Hasni, P.M. Izmirly, M. Jung, G. Kum\u00e1novics, X. Mariette, I. Padjen, J.M. Pego-Reigosa, J. Romero-Diaz, \u00cd. R\u00faa-Figueroa Fern\u00e1ndez, R. Seror, G.H. Stummvoll, Y. Tanaka, M.G. Tektonidou, C. Vasconcelos, E.M. Vital, D.J. Wallace, S. Yavuz, P.L. Meroni, M.J. Fritzler, R. Naden, T. D\u00f6rner, S.R. Johnson, 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus, Arthritis Rheumatol 71(9) (2019) 1400-1412.","DOI":"10.1002\/art.40930"},{"issue":"6","key":"10.1016\/j.intimp.2024.113840_b0065","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.intimp.2024.113840_b0070","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.intimp.2024.113840_b0075","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10067-020-05040-4","article-title":"Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus","volume":"39","author":"Zeng","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113840_b0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10238-021-00707-x","article-title":"The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity","volume":"21","author":"Zeng","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.113840_b0085","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0961203308100481","article-title":"European consensus statement on the terminology used in the management of lupus glomerulonephritis","volume":"18","author":"Gordon","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113840_b0090","doi-asserted-by":"crossref","unstructured":"Yanli Zeng, Yan Zhang, Yiqiang Lin, Xuelian Wang, Qinggui Chen, Qinghe Huang, Jiajia Wang, Longcan Jiang, Yun Xiao, The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity, Clin Exp Med (21) (2021) 611-619.","DOI":"10.1007\/s10238-021-00707-x"},{"issue":"9","key":"10.1016\/j.intimp.2024.113840_b0095","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/european league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113840_b0100","doi-asserted-by":"crossref","unstructured":"F. van den Hoogen, D. Khanna, J. Fransen, S.R. Johnson, M. Baron, A. Tyndall, M. Matucci-Cerinic, R.P. Naden, T.A. Medsger, Jr., P.E. Carreira, G. Riemekasten, P.J. Clements, C.P. Denton, O. Distler, Y. Allanore, D.E. Furst, A. Gabrielli, M.D. Mayes, J.M. van Laar, J.R. Seibold, L. Czirjak, V.D. Steen, M. Inanc, O. Kowal-Bielecka, U. M\u00fcller-Ladner, G. Valentini, D.J. Veale, M.C. Vonk, U.A. Walker, L. Chung, D.H. Collier, M. Ellen Csuka, B.J. Fessler, S. Guiducci, A. Herrick, V.M. Hsu, S. Jimenez, B. Kahaleh, P.A. Merkel, S. Sierakowski, R.M. Silver, R.W. Simms, J. Varga, J.E. Pope, 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative, Ann Rheum Dis 72(11) (2013) 1747-55.","DOI":"10.1136\/annrheumdis-2013-204424"},{"key":"10.1016\/j.intimp.2024.113840_b0105","doi-asserted-by":"crossref","unstructured":"N. Villegas-Zambrano, V.M. Mart\u00ednez-Taboada, A. Bol\u00edvar, M.S. Mart\u00edn, L. Alvarez, M.J. Mar\u00edn, M. L\u00f3pez-Hoyos, Correlation Between Clinical Activity and Serological Markers in a Wide Cohort of Patients with Systemic Lupus Erythematosus An Eight-year Prospective Study, in: Y. Shoenfeld, M.E. Gershwin (Eds.), Contemporary Challenges in Autoimmunity2009, pp. 60-66.","DOI":"10.1111\/j.1749-6632.2009.04650.x"},{"issue":"1","key":"10.1016\/j.intimp.2024.113840_b0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13075-019-2029-1","article-title":"Performance of cytokine models in predicting SLE activity","volume":"21","author":"Ruchakorn","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113840_b0115","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1007\/s10067-020-05040-4","article-title":"Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus","volume":"39","author":"Zeng","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113840_b0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10238-021-00759-z","article-title":"Factors associated with the antinuclear antibody (ANA) titer of systemic autoimmune rheumatic diseases in ANA-positive patients after treatment: a retrospective study","volume":"22","author":"Xiao","year":"2022","journal-title":"Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113840_b0125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.113840_b0130","unstructured":"C.R. Association, N.C.R.C.f.D.a.I. Diseases, C.S.L.E.T.a.R. Group, 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus, Chinese Journal of Internal Medicine 59(3) (2020) 172-185."},{"issue":"82","key":"10.1016\/j.intimp.2024.113840_b0135","first-page":"1","article-title":"Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus","volume":"22","author":"Zeng","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.intimp.2024.113840_b0140","unstructured":"Zeng Xiaofeng, 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus, Chin J Intern Med (3) (2020) 172-185."},{"issue":"12","key":"10.1016\/j.intimp.2024.113840_b0145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113840_b0150","article-title":"Reduced Neutrophil Extracellular Trap Formation During Ischemia Reperfusion Injury in C3 KO Mice: C3 Requirement for NETs Release","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113840_b0155","article-title":"Systemic Lupus Erythematosus with and without Anti-dsDNA Antibodies: Analysis from a Large Monocentric Cohort","volume":"2015","author":"Conti","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"11","key":"10.1016\/j.intimp.2024.113840_b0160","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00296-019-04426-1","article-title":"Neutrophil extracellular traps-associated markers are elevated in patients with systemic lupus erythematosus","volume":"39","author":"Jeremic","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2024.113840_b0165","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar4264","article-title":"Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus","volume":"15","author":"Leffler","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1189\/jlb.5BT0615-234R","article-title":"At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases","volume":"99","author":"Barnado","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2024.113840_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.910908","article-title":"Impact of Neutrophil Extracellular Traps on Thrombosis Formation: New Findings and Future Perspective","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113840_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250265","article-title":"ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo","volume":"16","author":"Hayden","year":"2021","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.intimp.2024.113840_b0185","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jgeb.2018.05.011","article-title":"Increased level of B cell differentiation factor in systemic lupus erythematosus patients","volume":"16","author":"Raslan","year":"2018","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113840_b0195","doi-asserted-by":"crossref","first-page":"24072","DOI":"10.1038\/srep24072","article-title":"Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2024.113840_b0200","doi-asserted-by":"crossref","first-page":"C287","DOI":"10.1152\/ajpcell.00319.2010","article-title":"Sca-1 influences the innate immune response during skeletal muscle regeneration","volume":"300","author":"Long","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113840_b0205","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00296-011-1962-3","article-title":"Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4","volume":"32","author":"Julkunen","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2024.113840_b0210","first-page":"51","article-title":"Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients","volume":"24","author":"Saisoong","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113840_b0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4049\/jimmunol.168.3.1036","article-title":"Complement C4 is protective for lupus disease independent of C3","volume":"168","author":"Einav","year":"2002","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T11:49:39Z","timestamp":1736596179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S1567576924023622"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113840","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil extracellular traps as a potential marker of systemic lupus erythematosus activity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113840"}}